Consensus Oscar Health, Inc.

Equities

OSCR

US6877931096

Market Closed - Nyse Other stock markets 04:00:02 2024-04-25 pm EDT			5-day change	1st Jan Change
17.89 ^USD	+1.71%		+8.75%	+95.52%

Mar. 22	Raymond James Starts Oscar Health With Outperform Rating, $20 Price Target	MT
Mar. 18	Oscar Health, Inc.(NYSE:OSCR) added to S&P Insurance Select Industry Index	CI

Evolution of the average Target Price on Oscar Health, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d028c6a52948d3a5b9b5b4223b187269.PzAgtQI9mIhKqZonI-koaz4QbV3QPd9lxgkoBGtgl5U.DHx49EB-1-ly5NBIfLFCA1ZcXRyWR74CsXxjZVsV78NOAmLQdWre0hDQ2w~b6a72aea76a4433058f4b8fbb48538b1

Analyst Recommendations on Oscar Health, Inc.

Raymond James Starts Oscar Health With Outperform Rating, $20 Price Target	Mar. 22	MT
Goldman Sachs Adjusts Price Target on Oscar Health to $16 From $8, Keeps Neutral Rating	Feb. 09	MT
BofA Upgrades Oscar Health to Buy From Neutral, Adjusts Price Target to $9 From $8	Nov. 02	MT
Morgan Stanley Raises Price Target on Oscar Health to $7.50 From $5, Maintains Equalweight Rating	23-08-30	MT
Goldman Sachs Adjusts Price Target on Oscar Health to $7.50 From $5.50, Keeps Neutral Rating	23-08-10	MT
Credit Suisse Adjusts Oscar Health's Price Target to $8.50 From $7, Keeps Outperform Rating	23-08-09	MT
Wells Fargo Adjusts Price Target on Oscar Health to $12 From $8.50, Maintains Overweight Rating	23-06-13	MT
BofA Securities Upgrades Oscar Health to Neutral From Underperform, Adjusts Price Target to $8.75 From $5.40	23-06-06	MT
Wells Fargo Raises Price Target on Oscar Health to $8.50 From $6.75, Maintains Overweight Rating	23-05-17	MT
Credit Suisse Lifts Oscar Health's Price Target to $7 From $6 After Above-Consensus Q1 Results, Keeps Outperform Rating	23-05-10	MT
Cowen Adjusts Price Target on Oscar Health to $6 From $3, Maintains Market Perform Rating	23-02-14	MT
Credit Suisse Trims Oscar Health's Price Target to $6 From $7, Keeps Outperform Rating	23-02-10	MT
Credit Suisse Trims Oscar Health's Price Target to $7 From $8, Keeps Outperform Rating	22-11-21	MT
Wells Fargo Upgrades Oscar Health to Overweight From Equal Weight, Price Target is $4	22-11-16	MT
Morgan Stanley Downgrades Oscar Health to Equalweight Rating From Overweight, Adjusts Price Target to $5 From $9	22-11-14	MT
Morgan Stanley Trims Price Target on Oscar Health to $9 From $12, Maintains Overweight Rating	22-09-01	MT
Credit Suisse Lowers Oscar Health's PT to $8 from $10 to Reflect Recent Developments in Managed Care Market, Maintains Outperform Rating	22-06-16	MT
BofA Securities Downgrades Oscar Health to Underperform From Neutral, Adjusts Price Target to $4.50 From $6	22-06-15	MT
BofA Securities Downgrades Oscar Health to Underperform From Neutral	22-06-15	MT
Morgan Stanley Adjusts Price Target for Oscar Health to $12 From $18, Maintains Overweight Rating	22-06-09	MT
BofA Securities Assess Risks to Managed Care Sector Amid Shifting Regulatory Environment, Market Disruption	22-05-26	MT
BofA Securities Downgrades Oscar Health to Neutral From Buy, Adjusts Price Target to $6 From $12	22-05-26	MT
Morgan Stanley Adjusts Oscar Health's Price Target to $18 from $20, Keeps Overweight Rating	22-03-28	MT
Goldman Sachs Upgrades Oscar Health to Neutral from Sell, Adjusts Price Target to $9 from $6.50	22-02-14	MT
Morgan Stanley Adjusts Oscar Health Price Target to $20 From $19, Maintains Overweight Rating	22-02-14	MT